T Cell Therapy of Opportunistic Cytomegalovirus Infection
NCT02982902
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Cytomegalovirus Infections
Hematopoietic Stem Cell Transplant
Opportunistic Infections
Interventions
BIOLOGICAL:
CMV specific adoptive t-cells
Sponsor
Mari Dallas